Dr. Ezra Cohen on the Efficacy and Pharmacokinetics of Cabozantinib

feeds has 409 videos Subscribe Here

Description: Ezra E.W. Cohen, MD, Associate Professor, Section of Hematology/Oncology, Department of Medicine, Co-Director, Head and Neck Cancer Program, Director, Hematology/Oncology Fellowship Program, University of Chicago Medical Center, discusses analyses of the phase III EXAM trial that examined the efficacy and pharmacokinetics of cabozantinib (XL184) for patients with advanced medullary thyroid cancer (MTC).

To view more information from the 2012 ESMO Congress, visit
Shared By : feeds
Posted on : 09/03/13
Added : 4 years ago

More From feeds

Nothing found.